These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17077550)

  • 1. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitors V. A series of new derivatives containing a spiro[imidazo[1,2-a]pyrazine-2(3H),4'-piperidin]-5(1H)-one scaffold.
    Saitoh F; Mukaihira T; Nishida H; Satoh T; Okano A; Yumiya Y; Ohkouchi M; Johka R; Matsusue T; Shiromizu I; Hosaka Y; Matsumoto M; Ohnishi S
    Chem Pharm Bull (Tokyo); 2006 Nov; 54(11):1535-44. PubMed ID: 17077550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitors IV. A series of new derivatives containing a spiro[5H-oxazolo[3,2-a]pyrazine-2(3H),4'-piperidin]-5-one skeleton.
    Nishida H; Mukaihira T; Saitoh F; Harada K; Fukui M; Matsusue T; Okamoto A; Hosaka Y; Matsumoto M; Shiromizu I; Ohnishi S; Mochizuki H
    Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):406-12. PubMed ID: 15056953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitors(1-6) VI. A series of new derivatives containing N,S- and N,SO2-spiro acetal scaffolds.
    Saitoh F; Nishida H; Mukaihira T; Kosuga N; Ohkouchi M; Matsusue T; Shiromizu I; Hosaka Y; Matsumoto M; Yamamoto I
    Chem Pharm Bull (Tokyo); 2007 Feb; 55(2):317-23. PubMed ID: 17268108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitor.
    Nishida H; Miyazaki Y; Kitamura Y; Ohashi M; Matsusue T; Okamoto A; Hosaka Y; Ohnishi S; Mochizuki H
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1237-44. PubMed ID: 11605647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitors III. Effect of ring opening of piperazinone moiety on inhibition.
    Nishida H; Miyazaki Y; Mukaihira T; Shimada H; Suzuki K; Saitoh F; Mizuno M; Matsusue T; Okamoto A; Hosaka Y; Matsumoto M; Ohnishi S; Mochizuki H
    Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):459-62. PubMed ID: 15056966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A facile synthesis and antimycobacterial evaluation of novel spiro-pyrido-pyrrolizines and pyrrolidines.
    Ranjith Kumar R; Perumal S; Senthilkumar P; Yogeeswari P; Sriram D
    Eur J Med Chem; 2009 Sep; 44(9):3821-9. PubMed ID: 19524332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitors.
    Shi Y; O'Connor SP; Sitkoff D; Zhang J; Shi M; Bisaha SN; Wang Y; Li C; Ruan Z; Lawrence RM; Klei HE; Kish K; Liu EC; Seiler SM; Schweizer L; Steinbacher TE; Schumacher WA; Robl JA; Macor JE; Atwal KS; Stein PD
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7516-21. PubMed ID: 22041058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple and facile synthesis of tetralone-spiro-glutarimides and spiro-bisglutarimides from Baylis-Hillman acetates.
    Basavaiah D; Reddy RJ
    Org Biomol Chem; 2008 Mar; 6(6):1034-9. PubMed ID: 18327328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorus-nitrogen compounds. Part 24. Syntheses, crystal structures, spectroscopic and stereogenic properties, biological activities, and DNA interactions of novel spiro-ansa-spiro- and ansa-spiro-ansa-cyclotetraphosphazenes.
    Elmas G; Okumuş A; Kılıç Z; Hökelek T; Açık L; Dal H; Ramazanoğlu N; Koç LY
    Inorg Chem; 2012 Dec; 51(23):12841-56. PubMed ID: 23163803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (+)- and (-)-Pestaloxazine A, a Pair of Antiviral Enantiomeric Alkaloid Dimers with a Symmetric Spiro[oxazinane-piperazinedione] Skeleton from Pestalotiopsis sp.
    Jia YL; Wei MY; Chen HY; Guan FF; Wang CY; Shao CL
    Org Lett; 2015 Sep; 17(17):4216-9. PubMed ID: 26291636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total synthesis and biological evaluation of spirotryprostatin A analogs.
    Ma Y; Fan C; Jia B; Cheng P; Liu J; Ma Y; Qiao K
    Chirality; 2017 Nov; 29(11):737-746. PubMed ID: 28906026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitors.
    Su T; Yang H; Volkots D; Woolfrey J; Dam S; Wong P; Sinha U; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2003 Feb; 13(4):729-32. PubMed ID: 12639568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic and biological studies on the spiro-mamakone system.
    Murphy AC; Devenish SR; Muscroft-Taylor AC; Blunt JW; Munro MH
    Org Biomol Chem; 2008 Oct; 6(20):3854-62. PubMed ID: 18843418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as a factor Xa inhibitor II. Substituent effect on biological activities.
    Nishida H; Miyazaki Y; Mukaihira T; Saitoh F; Fukui M; Harada K; Itoh M; Muraoka A; Matsusue T; Okamoto A; Hosaka Y; Matsumoto M; Ohnishi S; Mochizuki H
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1187-94. PubMed ID: 12237534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A concise synthesis of spirotryprostatin A.
    Miyake FY; Yakushijin K; Horne DA
    Org Lett; 2004 Nov; 6(23):4249-51. PubMed ID: 15524455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel, highly potent aldose reductase inhibitors: (R)-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4- tetrahydropyrrolo[1,2-a]pyrazine -4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (AS-3201) and its congeners.
    Negoro T; Murata M; Ueda S; Fujitani B; Ono Y; Kuromiya A; Komiya M; Suzuki K; Matsumoto J
    J Med Chem; 1998 Oct; 41(21):4118-29. PubMed ID: 9767647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H and 13C NMR signal assignments of some new spiro[7H-benzo[de]anthracene-naphthopyrans].
    Coelho PJ; Fernandes IC; Carvalho LM
    Magn Reson Chem; 2008 Mar; 46(3):295-8. PubMed ID: 18236439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total synthesis of (-)-spirotryprostatin B.
    Meyers C; Carreira EM
    Angew Chem Int Ed Engl; 2003 Feb; 42(6):694-6. PubMed ID: 12575009
    [No Abstract]   [Full Text] [Related]  

  • 19. Total Synthesis and Antifungal Activity of Palmarumycin CP17 and Its Methoxy Analogues.
    Wang R; Liu G; Yang M; Wang M; Zhou L
    Molecules; 2016 May; 21(5):. PubMed ID: 27164077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological activity of YM-60828 derivatives. Part 2: potent and orally-bioavailable factor Xa inhibitors based on benzothiadiazine-4-one template.
    Hirayama F; Koshio H; Katayama N; Ishihara T; Kaizawa H; Taniuchi Y; Sato K; Sakai-Moritani Y; Kaku S; Kurihara H; Kawasaki T; Matsumoto Y; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2003 Feb; 11(3):367-81. PubMed ID: 12517432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.